Recombinant Human Granulocyte/Macrophage Colonystimulating Factor（rhGM-CSF）
- Generic Name
- Recombinant Human Granulocyte/Macrophage Colonystimulating Factor（rhGM-CSF）
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于：1.恶性肿瘤、白血病化、放疗引起的白血病减少及其并发的感染；
2.造血干/祖细胞移植后髓系造血功能受抑及延迟植活与移植排斥；
3.与rhG-CSF等造血生长因子联合或单独应用于外周血造血干/祖细胞移植前的干/祖细胞动员；
4.再生障碍性贫血等骨髓衰竭性疾患及各种严重感染并发的中性粒细胞减少；
5.也可用于艾滋病本身、或因药物治疗所致的中性粒细胞减少。
- Associated Conditions
- -
- Associated Therapies
- -
Herceptin and GM-CSF for Metastatic Breast Cancer
- First Posted Date
- 2007-01-31
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00429104
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)
- Conditions
- Interventions
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00415857
- Locations
- 🇺🇸
UT MD . Anderson Cancer Center, Houston, Texas, United States
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2006-10-04
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00383994
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Cellular Immune Augmentation in Colon and Rectal Cancer
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 20
- Registration Number
- NCT00257322
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Rita Sanghvi, Mehta
- Target Recruit Count
- 48
- Registration Number
- NCT00256243
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Neoadjuvant Treatment of Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-11-16
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 43
- Registration Number
- NCT00254592
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT00208949
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 31
- Registration Number
- NCT00204516
- Locations
- 🇩🇪
Department of Dermatology, University of Tuebingen, Tuebingen, Germany
A Randomized Trial of GM-CSF in Patients With ALI/ARDS
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 132
- Registration Number
- NCT00201409
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸University of Colorado Health Sciences Center, Denver, Colorado, United States
Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
- Conditions
- First Posted Date
- 2004-01-14
- Last Posted Date
- 2021-10-14
- Target Recruit Count
- 96
- Registration Number
- NCT00076037
- Locations
- 🇺🇸
Saint Louis Univ. School of Medicine, HVTU, Saint Louis, Missouri, United States
🇺🇸FHCRC/UW Vaccine CRS, Seattle, Washington, United States
🇺🇸Alabama Vaccine CRS, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.